Ophthalmology

Top Story

Akorn shareholders approve Fresenius Kabi merger

July 21, 2017

Akorn shareholders have approved a merger with Fresenius Kabi, according to an Akorn press release.

Fresenius Kabi announced in April that it would acquire the company for $4.3 billion, or $34 per share. The agreement allowed for $450 million in debt to be assumed in the transaction, which is expected to close by early 2018.

In the Journals

Amniotic membrane transplantation adds to benefits of antibiotics in bacterial keratitis

July 20, 2017
The combination of amniotic membrane transplantation and antibiotic therapy leads to significantly better results than antibiotic therapy alone in eyes with bacterial…

NIH awards $1.9 million grant to study bacterial endophthalmitis

July 20, 2017
The National Eye Institute of the National Institutes of Health has awarded a $1.9 million grant to a Wayne State University School of Medicine researcher, according to…

Roclatan demonstrates positive safety results at 12 months in phase 3 trial

July 20, 2017
Aerie Pharmaceuticals released successful 12-month safety results for the Mercury 1 phase 3 registration trial for Roclatan, a once-daily eye drop to lower IOP. The…

Sustained-release therapies remove patient factor from glaucoma treatment

Ocular Surgery News U.S. Edition, July 25, 2017
Sustained delivery devices that take glaucoma therapy out of patients’ hands may be the answer to the many issues related to adherence, with significant benefits…
More News Headlines »
Original Article

Corneal Asphericity and IOL Power Calculation in Eyes With Aspherical IOLs

Journal of Refractive Surgery, July 2017, Volume 33 Issue 7
Given that a previous study found that corneal asphericity influences the refractive outcome of intraocular lens (IOL)…
More »
CME CE

EDUCATION FOR THE REFERRING EYE CARE SPECIALIST

Diagnosis and Treatment of Myopic Choroidal Neovascularization: Earlier is Better

This activity is supported by an educational grant from Genentech, Inc.

This activity for comprehensive ophthalmologists and optometrists reviews the pathology and symptoms of mCNV; makes…
More »
Resource Centers
Video
Meeting News

VIDEO: OCTANe CEO discusses formula for growing business in Orange County

June 23, 2017
More »
Advertisement
Advertisement